<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04262479711023</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:07.200Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711030</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:07.136Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711047</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:06.954Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711054</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:06.757Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711061</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:05.986Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711078</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:04.762Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711085</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:03.320Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711092</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:02.866Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711108</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA2030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:02.492Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711115</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:02.336Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711122</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>Q02030301</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:02.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711139</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:01.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711146</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:01.881Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711153</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:46:45.000Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711160</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:46:44.972Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711177</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA3030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:46:44.883Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710224</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName>Sterile Viscoelastic OVD (Ophthalmic Viscosurgical Device)</deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1012</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-08-04T18:29:10.509Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710231</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:47:25.928Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710248</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:47:25.404Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710255</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:47:25.093Z</lastUpdated>
  </row>
</eudamedExport>